Core Competency Module 12: Investigational Drug Principles

Core Competency Module 12: Investigational Drug Principles is organized by Hematology/Oncology Pharmacy Association (HOPA).,,End Date: 05-26-2023,,Course Description: ,This module educates pharmacists on investigational drug principles and the requirements of conduct of a clinical trial. The module describes various types of clinical trials and the goals of each trial phase, and it covers aspects of the pharmacist’s role in assuring compliance with federal regulations and prerequisites for appropriate investigational drug storage and temperature monitoring. Upon completion, pharmacists will obtain expertise in the documentation of drug accountability and knowledge of procedures, staffing, and workflow required to implement a pharmacy investigational drug service.,,Learning Objectives:,• Differentiate between the various phases of clinical trials. ,• Discuss pertinent requirements for drug accountability records. ,• Recognize standards for establishing investigational drug pharmacy services. ,• Identify standard operating procedures that are needed to ensure accurate storage and handling of investigational medications. ,• Describe the role of an investigational drug pharmacist. ,,Additional details will be posted as soon as information is available.